Natural Health Products Program Advisory Committee Meeting #10, September 19 and 20, 2011

The Natural Health Products Directorate (NHPD) has changed its name to the Natural and Non-prescription Health Products Directorate (NNHPD) subsequent to its recently expanded mandate to include the oversight of non-prescription and disinfectant drugs in addition to natural health products (NHPs). Please note that we are currently modifying documents to reflect this change.

   Thank you for your patience and understanding.

Place
Ottawa, Ontario
Date
September 19 and 20, 2011

Day 1 - September 19

  • Item #1
    • Forward Planning: Overview of Upcoming Activities Related to Natural Health Products
      Mr. Matthew Bown, Health Products and Food Branch Inspectorate
      Mr. David K Lee, Policy, Planning and International Affairs Directorate
      Ms. Sara O'Connor, NHPD

  • Item #2
    • Discussion and Feedback on Proposed Guiding Principles for Health Claims for Natural Health Products
      Ms. Christine Gillis, NHPD

Day 2 - September 20

  • Item #3
    • Discussion and Feedback on a Proposed Policy for Multi-Ingredient Natural Health Products
      Ms. Haiyan Wang, NHPD

  • Item #4
    • Discussion and Feedback on Pre-Cleared Information for Natural Health Products: Monograph Development
      Ms. Laurie Chapman, NHPD

Participants

Members

  • Mr. Robin Bell, Direct Sellers Association
  • Mr. Michel Caron (Alternate Member), National Association of Pharmacy Regulatory Authorities
  • Mr. Carl Carter, Canadian Health Food Association
  • Mr. Lawrence Cheng, Chamber of Chinese Herbal Medicine of Canada
  • Dr. Mary Chou, Advanced Orthomolecular Research Inc.
  • Mr. John Ferris, Swiss Herbal Remedies Ltd.
  • Ms. Suzanne Gaudette, Canadian Homeopathic Pharmaceutical Association
  • Dr. Dennis Gorecki, University of Saskatchewan
  • Mr. Adam Kingsley, Consumer Health Products Canada
  • Mr. Gary Leong, Jamieson Laboratories Inc.
  • Ms. Shawn O'Reilly, Canadian Association of Naturopathic Doctors
  • Mr. Ron Rosenes, Canadian Treatment Action Council
  • Ms. Hilary Schinkel, Wyeth Consumer Healthcare Inc.
  • Ms. Holly Vengroff, CARP: A New Vision of Aging For Canada
  • Dr. Terry Willard, Wild Rose Enterprises Inc.

  • Regrets:
    Ms. Paula Brown, British Columbia Institute of Technology
    Dr. Jawaid Younus, London Health Sciences Centre

Health Canada, Health Products and Food Branch (HPFB)

  • Mr. Marcin Boruk, Senior Policy Analyst, Office of Legislation and Regulatory Modernization, Policy, Planning and International Affairs Directorate (PPIAD) (Observer, Day 2)
  • Mr. Matthew Bown, Senior Policy Analyst, Health Products and Food Branch Inspectorate (HPFBI) (Day 1)
  • Ms. Laurie Chapman, Unit Head, Product Assessment Division, Bureau of Product Review and Assessment (BPRA), Natural Health Products Directorate (NHPD)
  • Ms. Diane Ciraco, Program Officer, Stakeholder Outreach and Engagement, Bureau of Policy and Risk Management (BPRM), NHPD
  • Ms. Monica Dhir, Senior Legal Analyst, PPIAD (Observer, Day 1)
  • Ms. Joanne Garrah, Associate Director, PPIAD (Observer, Day 1)
  • Mr. Adam Gibson, Senior Executive Director, BPRA, NHPD
  • Ms. Christine Gillis, Director, BPRM, NHPD
  • Mr. David K Lee, Director, Office of Legislation and Regulatory Modernization, PPIAD (Day 1- Item 1)
  • Ms. Rose Ngo, Product Information Officer, Therapeutic Products Directorate (TPD) (Observer, Day 2)
  • Ms. Sara O'Connor, Manager, Submission Management Division, BPRA, NHPD
  • Ms. Carol Toone, Manager, Stakeholder Outreach and Engagement, BPRM, NHPD
  • Ms. Haiyan Wang, Unit Head, Product Assessment Division, BPRA, NHPD
  • Ms. Christine Zaczynski, Compliance Coordinator, HPFBI (Observer)
  • Mr. Toufic Zayoun, Policy Analyst, TPD, (Observer, Day 1)

Facilitator

  • Ms. Raymonde D'Amour, Intersol Group
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: